\-\ Texto\\:\\ \ \(0\)\
\-\ palpable\\ lump\\ in\\ right\\ scrotum\\.\ \(0\)\
\-\ no\\ metastatic\\ disease\\ was\\ found\\;\\ patient\\ remains\\ asymptomatic\\ after\\ right\\ orchiectomy\\.\ \(0\)\
\-\ ultrasound\\ images\\ demonstrate\\ a\\ normal\\-sized\\ right\\ testicle\\ with\\ multiple\\ punctate\\ nonshadowing\\ echogenic\\ foci\\ \\(with\\ occasional\\ ring\\ down\\ artifact\\)\ \(0\)\
\-\ consistent\\ with\\ testicular\\ microliths\\.\\ \\ in\\ the\\ upper\\ pole\\ of\\ the\\ right\\ testicle\\ is\\ an\\ isoechoic\\ mass\\ which\\ was\\ new\\ from\\ a\\ prior\\ ultrasound\\ and\\ is\\ worrisome\\ for\\ a\\ germ\\ cell\\ tumor\\.\ \(0\)\
\-\ testicular\\ microlithiasis\ \(11\)\
\-\ testicular\\ microlithiasis\\ with\\ testicular\\ tumor\ \(0\)\
\-\ 50\\ yo\\ male\\ with\\ history\\ of\\ undescended\\ right\\ testicle\\ which\\ was\\ repaired\\ in\\ middle\\ age\\;\\ the\\ patient\\ had\\ this\\ ultrasound\\ for\\ a\\ palpabale\\ abnormality\\ in\\ the\\ right\\ scrotum\\.\\ \\ the\\ left\\ testicle\\ was\\ normal\\ on\\ sonography\\.\ \(0\)\
\-\ testicular\\ microlithias\\ is\\ an\\ uncommon\\ condition\\ \\(\\ prevalence\\ 0\\.68\\%\\ \\)\\ in\\ which\\ calcifications\\ are\\ present\\ within\\ the\\ seminal\\ vesicle\\ tubules\\.\\ \\ these\\ calcifications\\ can\\ occur\\ in\\ normal\\ as\\ well\\ as\\ cryptorchid\\ testes\\ and\\ have\\ been\\ reported\\ in\\ klinefelter\\'s\\ syndrome\\,\\ male\\ pseudohermaphroditism\\ and\ \(0\)\
\-\ testicular\\ neoplasms\\.\\ \\ bilateral\\ involvement\\ may\\ occur\\.\ \(0\)\
\-\ it\\ is\\ catagorized\\ into\\ limited\\ \\(less\\ than\\ 5\\ microliths\\)\\ and\\ classic\\ \\(at\\ least\\ 5\\ microliths\\)\\ forms\\.\\ \\ initially\\ felt\\ to\\ be\\ a\\ benign\\ process\\,\\ research\\ has\\ found\\ an\\ elevated\\ risk\\ for\\ co\\-existing\\ testicular\\ tumors\\.\\ \\ ultrasound\\ surveillance\ \(0\)\
\-\ may\\ be\\ necessary\\ for\\ these\\ patients\\.\ \(1\)\
\-\ for\\ additional\\ information\\,\\ see\\ w\\.d\\.\\ middleton\\ \\"testicular\\ microlithiasis\\:\\ prospective\\ analysis\\ of\\ prevalance\\ and\\ associated\\ tumor\\"\\ radiology\\ \\(2002\\)\\ 224\\:425\\-28\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ testicular\\:\\ 0\\.14317393061626724\ \(0\)\
\-\ microliths\\:\\ 0\\.0944927281873272\ \(0\)\
\-\ testicle\\:\\ 0\\.07763388430073599\ \(0\)\
\-\ microlithiasis\\:\\ 0\\.07478532517793005\ \(0\)\
\-\ scrotum\\:\\ 0\\.043420496836734844\ \(0\)\
\-\ ultrasound\\:\\ 0\\.04138975648989883\ \(0\)\
\-\ palpabale\\:\\ 0\\.03598170785292449\ \(0\)\
\-\ microlithias\\:\\ 0\\.03598170785292449\ \(0\)\
\-\ 0\\.68\\:\\ 0\\.03598170785292449\ \(0\)\
\-\ cryptorchid\\:\\ 0\\.03598170785292449\ \(0\)\
\-\ pseudohermaphroditism\\:\\ 0\\.03598170785292449\ \(0\)\
\-\ catagorized\\:\\ 0\\.03598170785292449\ \(0\)\
\-\ co\\-existing\\:\\ 0\\.03598170785292449\ \(0\)\
\-\ w\\.d\\:\\ 0\\.03598170785292449\ \(0\)\
\-\ prevalance\\:\\ 0\\.03598170785292449\ \(0\)\
\-\ 224\\:425\\-28\\:\\ 0\\.03598170785292449\ \(0\)\
\-\ klinefelter\\:\\ 0\\.031497576062442405\ \(0\)\
\-\ normal\\-sized\\:\\ 0\\.028668403896891605\ \(0\)\
\-\ nonshadowing\\:\\ 0\\.028668403896891605\ \(0\)\
\-\ undescended\\:\\ 0\\.028668403896891605\ \(0\)\
\-\ seminal\\:\\ 0\\.028039217448617083\ \(0\)\
\-\ vesicle\\:\\ 0\\.028039217448617083\ \(0\)\
\-\ middleton\\:\\ 0\\.028039217448617083\ \(0\)\
\-\ tubules\\:\\ 0\\.027013444271960323\ \(0\)\
\-\ worrisome\\:\\ 0\\.026194380208849503\ \(0\)\
\-\ occur\\:\\ 0\\.026171809214543176\ \(0\)\
\-\ calcifications\\:\\ 0\\.025936030650063287\ \(0\)\
\-\ isoechoic\\:\\ 0\\.025210045283066286\ \(0\)\
\-\ tumor\\:\\ 0\\.024394681244214015\ \(0\)\
\-\ research\\:\\ 0\\.023555085658135\ \(0\)\
\-\ prospective\\:\\ 0\\.02301005956579001\ \(0\)\
\-\ orchiectomy\\:\\ 0\\.02268335463651027\ \(0\)\
\-\ right\\:\\ 0\\.022080776549642855\ \(0\)\
\-\ found\\:\\ 0\\.02198388256695602\ \(0\)\
\-\ testes\\:\\ 0\\.021835847025170496\ \(0\)\
\-\ repaired\\:\\ 0\\.021710248418367422\ \(0\)\
\-\ surveillance\\:\\ 0\\.021710248418367422\ \(0\)\
\-\ prevalence\\:\\ 0\\.021470083112151366\ \(0\)\
\-\ sonography\\:\\ 0\\.020725913492584205\ \(0\)\
\-\ 5\\:\\ 0\\.020409472836278888\ \(0\)\
\-\ lump\\:\\ 0\\.02035460011215267\ \(0\)\
\-\ punctate\\:\\ 0\\.02035460011215267\ \(0\)\
\-\ forms\\:\\ 0\\.02026681968267935\ \(0\)\
\-\ which\\:\\ 0\\.019532382700929166\ \(0\)\
\-\ 2002\\:\\ 0\\.019070953867652923\ \(0\)\
\-\ information\\:\\ 0\\.0190066748596197\ \(0\)\
\-\ artifact\\:\\ 0\\.018525927775307933\ \(0\)\
\-\ occasional\\:\\ 0\\.018414095227601342\ \(0\)\
\-\ these\\:\\ 0\\.018153834220064002\ \(0\)\
\-\ remains\\:\\ 0\\.018147226822446846\ \(0\)\
\-\ germ\\:\\ 0\\.01804518069099616\ \(0\)\
\-\ neoplasms\\:\\ 0\\.017753511450252713\ \(0\)\
\-\ analysis\\:\\ 0\\.017753511450252713\ \(0\)\
\-\ least\\:\\ 0\\.017481301758421396\ \(0\)\
\-\ echogenic\\:\\ 0\\.017351715234688418\ \(0\)\
\-\ uncommon\\:\\ 0\\.01706444667647699\ \(0\)\
\-\ \\;\\:\\ 0\\.016534050517980358\ \(0\)\
\-\ felt\\:\\ 0\\.01640705256477452\ \(0\)\
\-\ pole\\:\\ 0\\.016241781702102127\ \(0\)\
\-\ ring\\:\\ 0\\.01620951566329758\ \(0\)\
\-\ was\\:\\ 0\\.016135143219815296\ \(0\)\
\-\ necessary\\:\\ 0\\.015449308173771685\ \(0\)\
\-\ may\\:\\ 0\\.015300639746107134\ \(0\)\
\-\ foci\\:\\ 0\\.01497152631491039\ \(0\)\
\-\ down\\:\\ 0\\.01497152631491039\ \(0\)\
\-\ for\\:\\ 0\\.014879758135565614\ \(0\)\
\-\ \\(\\:\\ 0\\.01474207604579307\ \(0\)\
\-\ radiology\\:\\ 0\\.01474086423220287\ \(0\)\
\-\ limited\\:\\ 0\\.014718499065816643\ \(0\)\
\-\ condition\\:\\ 0\\.014586822077170842\ \(0\)\
\-\ \\)\\:\\ 0\\.014561993716598063\ \(0\)\
\-\ an\\:\\ 0\\.01446936568511914\ \(0\)\
\-\ initially\\:\\ 0\\.01419583813985788\ \(0\)\
\-\ additional\\:\\ 0\\.013985496710816317\ \(0\)\
\-\ process\\:\\ 0\\.01342883871361108\ \(0\)\
\-\ classic\\:\\ 0\\.01336430562778805\ \(0\)\
\-\ 50\\:\\ 0\\.013269379659770632\ \(0\)\
\-\ tumors\\:\\ 0\\.013100883092532658\ \(0\)\
\-\ abnormality\\:\\ 0\\.012867583444206337\ \(0\)\
\-\ involvement\\:\\ 0\\.012783423088276803\ \(0\)\
\-\ middle\\:\\ 0\\.012755750896499747\ \(0\)\
\-\ reported\\:\\ 0\\.01271459122684005\ \(0\)\
\-\ risk\\:\\ 0\\.012633496519833008\ \(0\)\
\-\ male\\:\\ 0\\.012613922758265088\ \(0\)\
\-\ palpable\\:\\ 0\\.012361718541223636\ \(0\)\
\-\ new\\:\\ 0\\.012154236640002281\ \(0\)\
\-\ in\\:\\ 0\\.01203992086115014\ \(0\)\
\-\ benign\\:\\ 0\\.012036940273604904\ \(0\)\
\-\ elevated\\:\\ 0\\.011833944332077809\ \(0\)\
\-\ less\\:\\ 0\\.011812000017643603\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.011790173053045255\ \(0\)\
\-\ normal\\:\\ 0\\.010935611874278377\ \(0\)\
\-\ be\\:\\ 0\\.010757197741583097\ \(0\)\
\-\ age\\:\\ 0\\.010615960512425741\ \(0\)\
\-\ as\\:\\ 0\\.01055165310933982\ \(0\)\
\-\ yo\\:\\ 0\\.010495312340011274\ \(0\)\
\-\ see\\:\\ 0\\.010409049841750158\ \(0\)\
\-\ syndrome\\:\\ 0\\.009975128884631191\ \(0\)\
\-\ been\\:\\ 0\\.009488958732506087\ \(0\)\
\-\ cell\\:\\ 0\\.009421390659516271\ \(0\)\
\-\ is\\:\\ 0\\.009180257606281236\ \(0\)\
\-\ than\\:\\ 0\\.009138974918033772\ \(0\)\
\-\ patients\\:\\ 0\\.009026835099453168\ \(0\)\
\-\ prior\\:\\ 0\\.008955562335519852\ \(0\)\
\-\ metastatic\\:\\ 0\\.008780038382106491\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.00857197974543599\ \(0\)\
\-\ consistent\\:\\ 0\\.008552237831964096\ \(0\)\
\-\ bilateral\\:\\ 0\\.008464562160467119\ \(0\)\
\-\ upper\\:\\ 0\\.008416655123953953\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.00840714082441732\ \(0\)\
\-\ into\\:\\ 0\\.008299291297794723\ \(0\)\
\-\ associated\\:\\ 0\\.008230459436357968\ \(0\)\
\-\ \\%\\:\\ 0\\.008136004217738807\ \(0\)\
\-\ a\\:\\ 0\\.008093873506502066\ \(0\)\
\-\ demonstrate\\:\\ 0\\.008026335270747106\ \(0\)\
\-\ can\\:\\ 0\\.007911111642730896\ \(0\)\
\-\ well\\:\\ 0\\.007890126338647555\ \(0\)\
\-\ present\\:\\ 0\\.007877586750741555\ \(0\)\
\-\ it\\:\\ 0\\.007840197487889864\ \(0\)\
\-\ \\'s\\:\\ 0\\.007689986197416511\ \(0\)\
\-\ have\\:\\ 0\\.007552808483122824\ \(0\)\
\-\ had\\:\\ 0\\.007525917629553912\ \(0\)\
\-\ multiple\\:\\ 0\\.007346146952976609\ \(0\)\
\-\ after\\:\\ 0\\.007216331439221235\ \(0\)\
\-\ patient\\:\\ 0\\.006992587191154188\ \(0\)\
\-\ images\\:\\ 0\\.006690873028364711\ \(0\)\
\-\ within\\:\\ 0\\.006653597585249313\ \(0\)\
\-\ has\\:\\ 0\\.006549795797935829\ \(0\)\
\-\ disease\\:\\ 0\\.005700969555982467\ \(0\)\
\-\ from\\:\\ 0\\.005169125359813112\ \(0\)\
\-\ mass\\:\\ 0\\.004850861252847203\ \(0\)\
\-\ history\\:\\ 0\\.00481720219472279\ \(0\)\
\-\ are\\:\\ 0\\.004754587234814702\ \(0\)\
\-\ at\\:\\ 0\\.004725563889108706\ \(0\)\
\-\ \\:\\:\\ 0\\.004613366595880266\ \(0\)\
\-\ this\\:\\ 0\\.003923009033935237\ \(0\)\
\-\ left\\:\\ 0\\.003902470486828224\ \(0\)\
\-\ and\\:\\ 0\\.0036736531782085398\ \(0\)\
\-\ no\\:\\ 0\\.0035120169416481715\ \(0\)\
\-\ the\\:\\ 0\\.00338569676825206\ \(0\)\
\-\ \\,\\:\\ 0\\.0033148171287831108\ \(0\)\
\-\ on\\:\\ 0\\.002954657193328278\ \(0\)\
\-\ with\\:\\ 0\\.0023878403283650964\ \(0\)\
\-\ \\.\\:\\ 0\\.0020285449198483587\ \(0\)\
\-\ to\\:\\ 0\\.0017431351365019849\ \(0\)\
\-\ of\\:\\ 0\\.0014265771526284297\ \(0\)\
